Li Fraumeni syndrome, also known as sarcoma, breast, leukemia, and adrenal gland (SBLA) syndrome, is a rare inherited autosomal dominant disorder associated with abnormalities in TP53, a tumor suppressor protein gene. This activity illustrates the evaluation and management of Li Fraumeni syndrome and reviews the role of the interprofessional team in improving care for patients with this condition.

**Objectives:**
- Describe the role of TP53 in the etiology of Li Fraumeni syndrome.
- Explain the pathophysiology of Li Fraumeni syndrome.
- Summarize the Chompret criteria in the evaluation of Li Fraumeni syndrome.
- Review the importance of improving care coordination among the interprofessional team members to provide genetic counseling, medical care, and support services for patients affected by Li Fraumeni syndrome.